ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

STX Shield Therapeutics Plc

1.525
0.05 (3.39%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 3.39% 1.525 1.50 1.55 1.525 1.425 1.48 4,566,400 16:18:36
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.29 11.79M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.48p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £11.79 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.29.

Shield Therapeutics Share Discussion Threads

Showing 6476 to 6499 of 23275 messages
Chat Pages: Latest  271  270  269  268  267  266  265  264  263  262  261  260  Older
DateSubjectAuthorDiscuss
12/8/2020
10:44
Like the sound of a massive upside nobby. Will be adding before the end of the week. Atb
bobaxe1
12/8/2020
10:16
MMs caught and short....
nobbygnome
12/8/2020
08:35
All buys this morning. About to pop IMHO if there is any further volume of buying....
nobbygnome
11/8/2020
22:49
yes very good interview and very confident of next steps. I can see the share price 250p+ on deal announcement. I would buy more if I had the dosh! As a guess deal by eof Aug.2020? imho.
frrinvest
11/8/2020
18:50
He also states they will get approval in China which is a massive market
peachie 74
11/8/2020
18:06
With Tim's confidence in both interviews this is a screaming buy IMHO. As he says there is substantial upside when we get the deal....
nobbygnome
11/8/2020
17:43
Good interview with Tim although he is a bit hesitant in his delivery as usual. Seems confident about signing a US deal....

In fact there are 2 interviews there for the price of one as there is also a Proactive one as well.

nobbygnome
11/8/2020
16:13
The 5k trade at 117 is most definitely a buy 😜....
nobbygnome
11/8/2020
12:29
Flushed out a few bed wetters Friday and yesterday. Real gains % on highly anticipated US deal. Proactive Investors interview yesterday put myself a lot of my initial queries at ease.
itshenderz
11/8/2020
11:26
Yes. Just shows with this share how easy it can swing and catch people out. It drops quick , punters get scared and sell.
Next day up she goes and you can’t get back in anywhere near what you sold at.

peachie 74
11/8/2020
11:15
Tried to get 5k when the price was 115. There was nothing on the RSP so my broker went straight to the MMs. Both MMs on the offer had people queuing up to buy and both sold 2500 and then moved the price. So I was left without any but it just goes to show there is plenty of appetite for this stock at the moment.

I will wait and see what develops before trying to buy again....

nobbygnome
11/8/2020
10:25
Done all my adding, using spare funds to pile into a few other recovery plays, markets bullish this week.

This one, just hold and await news flow

ny boy
11/8/2020
10:16
This rises quick and falls quick.
Not many shares about in PI hands.
The PIs with any sense should hang on imo. Easy to get disheartened with no news. But you have to believe in the facts of this drug.

peachie 74
11/8/2020
10:01
Nice to see some vertical movement.
adman50
11/8/2020
09:27
End of summer is Sept 21st or so if memory serves.
tickboo
11/8/2020
09:16
Must be getting close to annoucement as we head towards end of summer. This was the feedback from CEO a a few months ago. Fingers crossed.
frrinvest
10/8/2020
13:26
Disappointing to see us sinking back down again. I had hoped to see a new floor after that rise last week. Oh well, of no consequence really as real deal news is what we are waiting for!
lovewinshatelosses
09/8/2020
09:30
Nobby - this is the quote I saw from the email I received from Alice Woodings at Shield on Friday, so all good I’d say... GLA :-
Edison’s forecasts remain unchanged but it states that the results ‘will have positive implications for health economic outcomes, pricing strategies and partnering opportunities’.

daveboy1
08/8/2020
16:57
>> borromini

Done....but don't forget it can be reinstated at a moment's notice 😜.....

nobbygnome
08/8/2020
16:55
Well our thoughts turn again back to the US licensing deal. I can't make up my mind whether the reanalysing of the data makes a US deal easier or not as the HtH data wasn't in the US file because of timing. Although the reps couldn't talk about the data MSLs probably can so on balance I think it does add extra value for a US company?
nobbygnome
07/8/2020
12:10
Joined you yesterday after the rns. Looks good to me in terms of the economic case. And I think can't have been far outside the 20% limit for the "non-inferiority" primary endpoint test.
1gw
07/8/2020
11:42
My reading of the data is that the treatment results are not significantly better than the IV option but much cheaper.
nashwan123
07/8/2020
11:31
i give up - go to Proactive Investors website and it's in the small cap section
shandypants2
07/8/2020
11:31
sorry link didn't copy. Hopefully this will work...

[...]

shandypants2
Chat Pages: Latest  271  270  269  268  267  266  265  264  263  262  261  260  Older

Your Recent History